AMP Capital Investors Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.

Quarter-by-quarter ownership
AMP Capital Investors Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$595,000
-50.5%
50,8980.0%0.00%
-42.9%
Q4 2019$1,203,000
+20.5%
50,8980.0%0.01%
+16.7%
Q3 2019$998,000
+6.4%
50,8980.0%0.01%
+20.0%
Q2 2019$938,000
+2.2%
50,898
+30.5%
0.01%0.0%
Q1 2019$918,000
-0.9%
38,9920.0%0.01%
-16.7%
Q4 2018$926,000
-30.3%
38,992
-8.0%
0.01%
-14.3%
Q3 2018$1,328,000
-19.3%
42,3700.0%0.01%
-22.2%
Q2 2018$1,646,00042,3700.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders